SUBSCRIBE
SUBSCRIBE
News   FDA

Almirall Gets FDA Approval for Migraine Drug

June 3, 2009 | 
1 min read
Reuters -- Spanish pharmaceutical firm Almirall on Wednesday said its Almotriptan migraine drug had gained U.S. Food and Drug Administration approval for adolescents.
FDA Approvals Asia Europe
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Rug pull crypto, scam coin, trading problem, investment risk in unstable and uncertainty stock market concepts. Unknown people pull carpet and make businesspeople who standing on money falling down.
FDA
FDA’s User Fee Negotiation Teams Gutted by Layoffs: Reuters
April 18, 2025
 · 
2 min read
 · 
Tristan Manalac
Food and Drug Administration building
FDA
FDA Moves to Restrict Industry Influence on Advisory Committees
April 18, 2025
 · 
2 min read
 · 
Tristan Manalac
Facade of the FDA's office in Maryland
Policy
RFK Jr. Eyes Changes to Vaccines Injury Surveillance System to Deduce ‘Culprit’
April 17, 2025
 · 
2 min read
 · 
Tristan Manalac
Diverse cultures, international communication concept. Human silhouette with speech bubbles.
Regulatory
Former FDA Officials Sound Alarm: Visible Changes May Be ‘Tip of the Iceberg’
April 16, 2025
 · 
3 min read
 · 
Heather McKenzie